Aevi Genomic Medicine Inc. (GNMX) Tumbled -5.02% or -0.12 To Price $2.27 On Tuesday

Aevi Genomic Medicine Inc. (GNMX) tumbled -5.02% or -0.12 to $2.27. It is near 165000 shares traded, which is 52.56% compare to the average total volume 313945. The market cap of GNMX is $134.68 million. The year to date change is 92.74%. The 52 week price range is from $0.98 to $6.18. Price of GNMX have changed 5.75% during last week. It have changed 83.85% over last month, 57.24% over last 3 months, 70.71% over last 6 months and -51.12% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNMX is 1.45. It is -36.12% below current price. The 200-day Moving Averages for GNMX is 1.38. It is -39.21% below current price. The 52-week High is 6.18. It is 172.25% from the current price. The 52-week Low is 0.98. It is -56.83% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GNMX is 1.95 on 2018-01-31. Short % to float is 0.83%. There are some statistics of GNMX. It is has market cap $134.68 million. The share outstanding is 59.33 million. The average volume is 313945. The percent of top 15 Institution holding is 51.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNMX is -136.18%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNMX is -110.41%.


Share this post